05 May 2005
Density of platelet collagen receptors glycoprotein VI and α2β1 and prior myocardial infarction in human subjects, a pilot study
Frederick F Samaha, Christopher Hibbard, Jay Sacks, Hong Chen, Michael A Varello, Thomas George, Mark L KahnMed Sci Monit 2005; 11(5): CR224-229 :: ID: 16137
Abstract
Background:Prior studies evaluating whether platelet collagen receptors affect risk of myocardial infarction (MI) have used common polymorphisms thought to affect receptor density, and have yielded conflicting results. Our objective in the current pilot study was to obtain preliminary information on the relationship between platelet collagen receptor density and prior MI.Material/Methods:We measured glycoprotein VI (GPVI) and integrin α2β1 density by flow cytometry using FITC-conjugated monoclonal antibodies in consecutive subjects from an outpatient cardiology practice. We used a case-control design to match 77 patients with prior MI to 77 control patients. Matching was performed on the basis of traditional risk factors for MI.Results:The mean GPVI density was 14% higher in those with prior MI (P=0.098), and the α2β1 density was 6% higher in those with prior MI (P=0.49). A GPVI or α2β1 density within the lowest decile was associated with a lower MI prevalence (OR=6.3, 95% CI: 1.3-29.2 P=0.009).Conclusions:Our preliminary data suggests that platelet collagen receptor density, when measured directly, may be related to prior myocardial infarction. An appropriately sized clinical study using this methodology is warranted to further investigate whether collagen receptor density serves as a novel risk factor for myocardial infarction.
Keywords: Integrin alpha2beta1 - blood, Myocardial Infarction - blood, Platelet Membrane Glycoproteins - genetics, Receptors, Collagen - blood, Receptors, Collagen - genetics, Blood Platelets - metabolism, Case-Control Studies, Genotype, Integrin alpha2beta1 - blood, Myocardial Infarction - immunology, Pilot Projects, Platelet Membrane Glycoproteins - metabolism, Polymorphism, Genetic, Receptors, Collagen - genetics
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952